RxDoctor Payments Data

Amy Hatcher

Family · Bowling Green, KYNPI 1669872362

Payments from drug & device makers

$4,447in general payments, 2019–2025

Across 71 payments — averaging $62.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Si-bone, Inc.$3K
  • AbbVie$531
  • Pfizer$250
  • Medical Device Business Services, Inc.$107
  • Johnson & Johnson$85
  • Pacira Pharmaceuticals Incorporated$38
  • plus $235 from 11 others

What the payments were for

  • Consulting fees$2,82063%
  • Travel & lodging$2496%
  • Food & beverage$1,37931%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,447 in reported general payments places this provider in the 90th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$35,444
Medicare patients
254
Services billed
431

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
UbrelvyUbrogepant112$144,909
Nurtec OdtRimegepant Sulfate89$105,963
QuliptaAtogepant76$86,603
Aimovig AutoinjectorErenumab-Aooe60$53,357
Emgality PenGalcanezumab-Gnlm31$20,854
Carbidopa-LevodopaCarbidopa/Levodopa182$3,632
Memantine Hcl132$2,534
Levetiracetam121$2,347
Gabapentin219$2,274
Propranolol Hcl ErPropranolol Hcl120$2,138
Carbidopa-Levodopa ErCarbidopa/Levodopa78$1,775
Ondansetron Hcl21$1,700
Pregabalin89$1,685
Rivastigmine14$1,542
Donepezil Hcl176$1,324

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy, Qulipta$531$231,511188 claims
PfizerNurtec Odt$250$105,96389 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,374 family providers in Kentucky.

Other family in Bowling Green

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →